DocuSign (DOCU) Expands IAM With Perplexity, Is The Stock Still Cheap?

DocuSign (DOCU) is back in focus after the company extended its Intelligent Agreement Management platform to Perplexity Computer and Computer for Counsel, bringing AI driven contract automation directly into legal and cross functional workflows.

See our latest analysis for DocuSign.

Despite the new IAM integrations with Perplexity and Slackbot drawing attention to DocuSign’s AI capabilities, the stock’s 1-day share price return of 6.48% sits against a year-to-date share price decline of 30.29% and a 1-year total shareholder return decline of 40.88%, suggesting recent momentum has picked up after a weaker stretch.

If you are looking beyond DocuSign for other AI driven opportunities, it could be a useful moment to scan the market using the 33 AI small caps

So with DocuSign’s shares down sharply over the past year yet showing fresh interest around its AI driven IAM push, are you looking at an undervalued software stock here, or is the market already pricing in the next leg of growth?

Most Popular Narrative: 24.9% Undervalued

Against DocuSign’s last close of $45.21, the most followed narrative anchors its fair value at $60.16, implying a sizable gap the market has not closed.

Rollout and ramp up of the IAM platform, with AI native features and deep enterprise system integrations, is unlocking significant upsell opportunities as customers migrate from core eSignature to broader agreement management, driving improved ARPU and supporting double digit future topline growth.

Read the complete narrative.

If you want to see why this fair value sits well above today’s DocuSign share price, look at how the narrative ties agreement volumes, pricing power, and long run margins together.

Result: Fair Value of $60.16 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, DocuSign’s story could change quickly if core eSignature demand matures faster than expected, or if competition and AI driven alternatives start to pressure pricing power.

Find out about the key risks to this DocuSign narrative.

Next Steps

With mixed sentiment around DocuSign’s risks and rewards, this is a useful time to review the data for yourself and form a clear view. To see both sides in one place, start with the 2 key rewards and 1 important warning sign.

Looking for more investment ideas beyond DocuSign?

If DocuSign has sharpened your focus on where capital goes next, do not stop here. Use data driven stock lists to pressure test your next move.

• Target potential mispricings by scanning for quality companies trading at a discount using the 44 high quality undervalued stocks.
• Prioritize resilience by filtering for businesses with stronger financial footing through the solid balance sheet and fundamentals stocks screener (48 results).
• Hunt for underfollowed opportunities that others might be missing with the screener containing 19 high quality undiscovered gems.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com